Endothelial Cell Differentiation from iPSCs
iPSC-derived endothelial cells (EC) are valuable tools that can help researchers better understand vascular diseases. At ASC, we use a fast, cost-effective differentiation procedure that allows our team to deliver high-quality cells in as little as 3 weeks. As one of the few provides of EC differentiation, we offer our customers a flexible standard service and the ability to fully customize their projects. For example, while our service includes standard characterization, additional characterization and downstream assay development services are available.
- Optimized & efficent differentiation protocols
- Our team can work with your iPSCs, one of ASC's control lines, or we can generate your iPSCs
- Well-characterized cells delivered in a few weeks
- Affordable Prices
- Standard or Customizable Service Options
Whether you are looking for endothelial cells for your disease modeling or drug screening projects, ASC has the capacity to not only differentiate your healthy/disease iPSCs, but our team of iPSC experts can also genetically modify your cells prior to the differentiation process with our high-throughput CRISPR genome editing platform. As a one-stop shop for all your iPSC needs, we strive to offer you a diversity of iPSC solutions, so if you would like to learn more about our endothelial cell differentiation service packages, contact us today.
Products and Services
Case Study 1
Differentiation of ASE-9211 iPSCs into Endothelial Cells
Figure 1: Morphology images captured throughout the iPSC to endothelial cell differentiation process.
Figure 2: Immunostaining for EC Markers.
Figure 3: Functional Assay for Characterizing Endothelial Cells.